Cargando…

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma

BACKGROUND: Glioblastoma patients show a great variability in progression free survival (PFS) and overall survival (OS). To gain additional pretherapeutic information, we explored the potential of O-(2-(18)F-fluoroethyl)-L-tyrosine (FET) PET as an independent prognostic biomarker. METHODS: We retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poulsen, Sidsel Højklint, Urup, Thomas, Grunnet, Kirsten, Christensen, Ib Jarle, Larsen, Vibeke Andrée, Jensen, Michael Lundemann, af Rosenschöld, Per Munck, Poulsen, Hans Skovgaard, Law, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5281673/ https://www.ncbi.nlm.nih.gov/pubmed/27554774 http://dx.doi.org/10.1007/s00259-016-3494-2

Ejemplares similares

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
por: Urup, Thomas, et al.
Publicado: (2020)

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
por: Abedi, Armita Armina, et al.
Publicado: (2021)

Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma
por: Frandsen, Simone, et al.
Publicado: (2019)

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
por: Michaelsen, Signe Regner, et al.
Publicado: (2013)

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
por: Poulsen, Hans Skovgaard, et al.
Publicado: (2014)

Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [(18)F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastoma
por: Henriksen, Otto M., et al.
Publicado: (2022)

(18)F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma
por: Nedergaard, Mette Kjoelhede, et al.
Publicado: (2015)

Predicting survival of glioblastoma from automatic whole-brain and tumor segmentation of MR images
por: Pálsson, Sveinn, et al.
Publicado: (2022)

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
por: Kristensen, Lasse S., et al.
Publicado: (2016)

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas
por: Michaelsen, Signe Regner, et al.
Publicado: (2018)

Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation
por: Fougner, Vincent, et al.
Publicado: (2022)

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study
por: Nørøxe, Dorte Schou, et al.
Publicado: (2019)

Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective
por: Marner, Lisbeth, et al.
Publicado: (2016)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Presentation of Two Cases with Early Extracranial Metastases from Glioblastoma and Review of the Literature
por: Johansen, Maria Dinche, et al.
Publicado: (2016)

A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis
por: Chiranth, Shivani, et al.
Publicado: (2023)

Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study
por: Clausen, Malene Martini, et al.
Publicado: (2014)

Hallmarks of glioblastoma: a systematic review
por: Nørøxe, Dorte Schou, et al.
Publicado: (2017)

Simulating intrafraction prostate motion with a random walk model
por: Pommer, Tobias, et al.
Publicado: (2017)

Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging
por: Liesche-Starnecker, Friederike, et al.
Publicado: (2021)

Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
por: Henriksson, Roger, et al.
Publicado: (2011)

The Use of Longitudinal (18)F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts
por: Nedergaard, Mette K., et al.
Publicado: (2014)

Residual positioning errors and uncertainties for pediatric craniospinal irradiation and the impact of image guidance
por: Gram, Daniel, et al.
Publicado: (2020)

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
por: Urup, Thomas, et al.
Publicado: (2017)

Extracranial metastases in glioblastoma—Two case stories
por: Schou Nørøxe, Dorte, et al.
Publicado: (2018)

Visual outcome after fractionated stereotactic radiation therapy of benign anterior skull base tumors
por: Astradsson, Arnar, et al.
Publicado: (2014)

Prospective assessment of the quality of life before, during and after image guided intensity modulated radiotherapy for prostate cancer
por: Sveistrup, Joen, et al.
Publicado: (2016)

Evaluation of the HD-GLIO Deep Learning Algorithm for Brain Tumour Segmentation on Postoperative MRI
por: Sørensen, Peter Jagd, et al.
Publicado: (2023)

Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance
por: Sveistrup, Joen, et al.
Publicado: (2014)

Volumetric modulated arc therapy dose prediction and deliverable treatment plan generation for prostate cancer patients using a densely connected deep learning model
por: Lempart, Michael, et al.
Publicado: (2021)

Cytokines and Type 1 Diabetes: A Numbers Game
por: Grunnet, Lars Groth, et al.
Publicado: (2011)

Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study
por: Clausen, Malene M, et al.
Publicado: (2013)

Evaluation of single-fraction high dose FLASH radiotherapy in a cohort of canine oral cancer patients
por: Børresen, Betina, et al.
Publicado: (2023)

Cerebral infarction after fractionated stereotactic radiation therapy of benign anterior skull base tumors
por: Astradsson, Arnar, et al.
Publicado: (2019)

Flow Cytometric Bivariate Analysis of DNA and Cytokeratin in Colorectal Cancer
por: Post, Carolin, et al.
Publicado: (2002)

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro
por: Staberg, Mikkel, et al.
Publicado: (2016)

Stability of percutaneously implanted markers for lung stereotactic radiotherapy
por: Persson, Gitte F., et al.
Publicado: (2013)

Mucosal expression of PI3, ANXA1, and VDR discriminates Crohn’s disease from ulcerative colitis
por: James, Jaslin Pallikkunnath, et al.
Publicado: (2023)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_13g7kqjtr3262c1qql2u12i00o